The transition from siloed systems to a unified regulatory information management (RIM) platform that fully supports end-to-end business processes is underway.
There are many different RIM solutions on the market and for a pharmaceutical company it is important to select a RIM solution that fits it’s needs. Not a single Pharma company is the same; with regards to the number of Marketing Authorisations, type of products, region of activities, manufacturer of finished product and/or active substance, etc.
The implementation of a RIM solution is a company strategic decision and involves a significant investment. Therefore, it is important to make a proper selection of the final technical solution based on the requirements and needs.
Veeva and Asphalion have joined forces developing a “white paper” that examines the business drivers behind this change. As a result, we have identified 3 critical factors to maximize the benefits of a unified RIM solution. English Version | Spanish Version
Asphalion is a global Scientific and Regulatory Affairs consultancy that can support you in the selection and implementation of a unified RIM solution to help meet IDMP requirements and optimize regulatory processes.